Shionogi: Other Countries Must Follow UK’s Lead On Antimicrobial Incentives

Shionogi’s UK general manager praised NHS England’s novel subscription model for antibiotics, but warned the country would be “wasting money” unless other global regulators introduced similar incentives for antimicrobial development.